Miller Derek

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 69% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Miller Derek's trades of Amgen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Amgen Inc (AMGN)
Transaction date
Sale
Price
150.46
Quantity 64,126 +2.1%
Value US$80,403
US Amgen Inc (AMGN)
Transaction date
Sale
Price
38.86
Quantity 30,724 +35.5%
Value US$1,765,625
US Amgen Inc (AMGN)
Transaction date
Proposed sale
Price
460.51
Quantity 35,036
Value US$4,184,838
US Amgen Inc (AMGN)
Transaction date
Sale
Price
293.74
Quantity 1,524 -15.1%
Value US$447,655
US Amgen Inc (AMGN)
Transaction date
Proposed sale
Price
293.74
Quantity 1,524
Value US$447,655
US Amgen Inc (AMGN)
Transaction date
Sale
Price
292.56
Quantity 500 -5.5%
Value US$146,279
US Amgen Inc (AMGN)
Transaction date
Proposed sale
Price
292.56
Quantity 500
Value US$146,279
Transaction date
Sale
Price
4.60
Quantity 21,251
Value £97,755
Transaction date
Sale
Price
5.00
Quantity 13,520
Value £67,600
Transaction date
Sale
Price
5.00
Quantity 993,758
Value £4,968,790
Transaction date
Planned purchase
Price
14.61
Quantity 205
Value £2,995
Transaction date
Planned purchase
Price
11.89
Quantity 509
Value £6,050
Transaction date
Sale
Price
12.38
Quantity 7,000
Value £86,660
Transaction date
Planned purchase
Price
11.50
Quantity 239
Value £2,748
Transaction date
Purchase
Price
4.17
Quantity 5,000
Value £20,830
Transaction date
Planned purchase
Price
14.78
Quantity 355
Value £5,248
Transaction date
Planned purchase
Price
13.29
Quantity 179
Value £2,379
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-06
US Amgen Inc (AMGN)
S Sale
64,126 +2.1%
150.46
US$80,403 		64,126 +2.1% 150.46 US$80,403
2026-08-07 2026-08-06
US Amgen Inc (AMGN)
S Sale
30,724 +35.5%
38.86
US$1,765,625 		30,724 +35.5% 38.86 US$1,765,625
2026-08-06 2026-08-06
US Amgen Inc (AMGN)
PrS Proposed sale
35,036
460.51
US$4,184,838 		35,036 460.51 US$4,184,838
2025-02-20 2025-02-19
US Amgen Inc (AMGN)
S Sale
1,524 -15.1%
293.74
US$447,655 		1,524 -15.1% 293.74 US$447,655
2025-02-19 2025-02-19
US Amgen Inc (AMGN)
PrS Proposed sale
1,524
293.74
US$447,655 		1,524 293.74 US$447,655
2025-02-20 2025-02-18
US Amgen Inc (AMGN)
S Sale
500 -5.5%
292.56
US$146,279 		500 -5.5% 292.56 US$146,279
2025-02-18 2025-02-18
US Amgen Inc (AMGN)
PrS Proposed sale
500
292.56
US$146,279 		500 292.56 US$146,279
2022-10-27 2022-10-25
S Sale
21,251
4.60
£97,755 		21,251 4.60 £97,755
2020-07-24 2020-07-23
S Sale
13,520
5.00
£67,600 		13,520 5.00 £67,600
2020-07-23 2020-07-23
S Sale
993,758
5.00
£4,968,790 		993,758 5.00 £4,968,790
2020-01-13 2020-01-08
PP Planned purchase
205
14.61
£2,995 		205 14.61 £2,995
2019-07-03 2019-07-02
PP Planned purchase
509
11.89
£6,050 		509 11.89 £6,050
2019-04-01 2019-03-29
S Sale
7,000
12.38
£86,660 		7,000 12.38 £86,660
2019-01-07 2019-01-04
PP Planned purchase
239
11.50
£2,748 		239 11.50 £2,748
2018-10-24 2018-10-24
B Purchase
5,000
4.17
£20,830 		5,000 4.17 £20,830
2018-07-05 2018-07-02
PP Planned purchase
355
14.78
£5,248 		355 14.78 £5,248
2018-01-08 2018-01-05
PP Planned purchase
179
13.29
£2,379 		179 13.29 £2,379